Tooth-regeneration drug advances to first patient trial in major dental breakthrough

A groundbreaking effort to regenerate human teeth has moved a significant step closer to reality as a Japanese biotechnology company prepares to launch its first clinical trial in patients with the condition the therapy is designed to treat. Japan-based Toregem BioPharma, a spin-out from Kyoto University, has announced plans to begin a Phase II clinical trial of its experimental tooth-regeneration drug, TRG035, in patients with severe congenital hypodontia—a rare developmental condition characterized by the absence of six or more permanent teeth. The announcement follows the company's successful fundraising round, which secured approximately US$5.3 million, bringing its total funding, including grants and subsidies, to more than US$29 million. A new approach to growing teeth Unlike conventional dental treatments such as implants, bridges, and dentures, the experimental therapy is designed to stimulate the body's own ability to generate new teeth. TRG035 works by targeting and blocking USAG-1 (Uterine Sensitization-Associated Gene-1), a protein known to suppress tooth development. Researchers believe that inhibiting this protein may activate dormant tooth buds that remain within the jaw, potentially triggering the growth of entirely new teeth. The scientific concept is based on the long-standing theory that humans may retain the biological potential for a third dentition—an additional set of teeth beyond the primary and permanent dentitions that normally develop during life. Researchers suggest that these vestigial tooth buds exist but typically remain inactive because of biological signaling pathways that prevent their development. First step into target patients The upcoming Phase II trial marks an important milestone because it will be the first time the drug is tested in patients suffering from the condition it is intended to treat. According to Toregem BioPharma, earlier Phase I studies involving healthy adults with at least one missing tooth were completed without serious adverse events, supporting further investigation of the treatment's safety profile. However, researchers emphasize that the therapy remains experimental and has not yet been proven to regenerate teeth in humans. The Phase II study is designed to evaluate whether the treatment can successfully stimulate tooth development in patients with severe congenital hypodontia. Why the breakthrough matters For children born with severe congenital hypodontia, treatment options remain limited. Because dental implants generally cannot be placed until jaw growth is complete, many young patients must rely on removable prostheses for years. This can affect chewing ability, speech development, nutrition, self-confidence, and overall quality of life. If successful, regenerative tooth therapy could fundamentally transform care for these patients by offering a biological alternative to traditional prosthetic replacement. Potential implications beyond rare diseases Although the initial focus is on congenital hypodontia, researchers envision broader applications in the future. Millions of people worldwide lose teeth because of trauma, periodontal disease, decay, or other acquired conditions. Scientists hope that regenerative approaches targeting dormant tooth-forming mechanisms may eventually provide new treatment options for adult tooth loss as well. However, experts caution that such applications remain years away and will require extensive clinical evidence demonstrating safety, effectiveness, and long-term outcomes. A milestone for regenerative dentistry The launch of a patient trial represents one of the most closely watched developments in regenerative dentistry. While many questions remain unanswered, the study signals growing momentum in efforts to move beyond artificial tooth replacement and toward biological tooth regeneration. If future trials confirm efficacy, the technology could open a new chapter in dental medicine—one in which the body's own developmental pathways are harnessed to restore missing teeth. For now, scientists and dental professionals worldwide will be closely watching the results of the upcoming study as researchers attempt to turn one of dentistry's most ambitious goals into clinical reality. Stay informed, stay alert CLICK HERE TO JOIN Dental News Pakistan on WhatsApp for real-time updates on healthcare, education, and public safety.